Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study

19 Aug 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to IgG4-Related and Inflammatory Diseases
Share to Neuroendocrine Tumor Research Advances
Share to Sinusitis and nasal conditions

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 40829952
DOI: 10.1016/j.ejim.2025.106459

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort studyPMID 40829952Read ↗

IgG4-related disease: an update on pathophysiology and implications for clinical careSemantic proximity Read ↗

Distinct Clinical Phenotypes and Treatment Responses in IgG4-Related Disease: Insights From a Tertiary Care Centre in Western India.Semantic proximity Read ↗

Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology-European League Against Rheumatism classification criteria.Semantic proximity Read ↗

IgG4 ‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic TargetsSemantic proximity Read ↗

Advances in the diagnosis and management of IgG4 related disease.Semantic proximity Read ↗

FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.Semantic proximity Read ↗

Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes.Semantic proximity Read ↗

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.Semantic proximity Read ↗

Clinical Characteristics and Therapeutic Response of Immunoglobulin G4-Related Disease: a Retrospective Study of 127 Chinese PatientsSemantic proximity Read ↗

Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infectionSemantic proximity Read ↗

Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4).Semantic proximity Read ↗

Impact of FCGR2A and FCGR3A Gene Variants on the Response to Rituximab in Patients With Glomerular Diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.